- Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials The New York Times
- Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says CNN
- Novo Nordisk shares slide after Ozempic pill fails in Alzheimer’s trials The Guardian
- Obesity jab drug fails to slow Alzheimer’s BBC
- There’s still hope GLP-1 drugs could slow the second-biggest type of dementia MarketWatch
Source link